The key assay component is the flexible recombinant M13@anti-CEA-scFv probe (M13 and CEA stand for M13 phage and carcinoembryonic antigen, respectively), which has a high affinity for CEA antigen expressed on the surface of intestinal cancer cells, as confirmed by ELISA. Here, CEACAM5 is linked to intestinal cancer.